Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 7Cardiotoxicity 5Lymphoma 3Heart Failure 3Glioblastoma 2Ventricular Dysfunction 1Sarcoma 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Multiple Myeloma 1Motor Activity 1Leukemia, Myeloid, Acute 1Leukemia 1Hepatocellular Carcinoma With Portal Vein Thrombosis 1Hematologic Neoplasms 1Cardiovascular Abnormalities 1Cardiomyopathies 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Temozolomide 264Radiotherapy 119Bevacizumab 105Magnetic Resonance Spectroscopy 59Radiation 47pembrolizumab 30Irinotecan 28Surgical Procedures, Operative 23Lomustine 21Specimen Handling 19Nivolumab 19Radiosurgery 18Carmustine 18Aminolevulinic Acid 16Erlotinib Hydrochloride 15Drug Therapy 15Blood Specimen Collection 14Radiotherapy, Intensity-Modulated 13O(6)-benzylguanine 13Chemotherapy, Adjuvant 13Carboplatin 13Filgrastim 11Cyclophosphamide 11sargramostim 10poly ICLC 10atezolizumab 10Thalidomide 10Etoposide 10Ipilimumab 9Everolimus 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Glioblastoma × Carvedilol × Clear all
NCT03861598 2021-09-24

Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells

West Virginia University

Phase EARLY_PHASE1 Terminated
4 enrolled
CNS

Glioblastoma

NCT03980249 2021-04-12

Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells

West Virginia University

Phase EARLY_PHASE1 Withdrawn
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡